Compugroup Medspadr 1 Stock Net Income
| COPA Stock | EUR 22.00 1.00 4.76% |
COMPUGROUP MEDSPADR 1 fundamentals help investors to digest information that contributes to COMPUGROUP MEDSPADR's financial success or failures. It also enables traders to predict the movement of COMPUGROUP Stock. The fundamental analysis module provides a way to measure COMPUGROUP MEDSPADR's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to COMPUGROUP MEDSPADR stock.
COMPUGROUP |
COMPUGROUP MEDSPADR 1 Company Net Income Analysis
COMPUGROUP MEDSPADR's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current COMPUGROUP MEDSPADR Net Income | 72.32 M |
Most of COMPUGROUP MEDSPADR's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, COMPUGROUP MEDSPADR 1 is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, COMPUGROUP MEDSPADR 1 reported net income of 72.32 M. This is 78.81% lower than that of the Healthcare sector and significantly higher than that of the Health Information Services industry. The net income for all Germany stocks is 87.33% higher than that of the company.
COMPUGROUP Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses COMPUGROUP MEDSPADR's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of COMPUGROUP MEDSPADR could also be used in its relative valuation, which is a method of valuing COMPUGROUP MEDSPADR by comparing valuation metrics of similar companies.COMPUGROUP MEDSPADR is currently under evaluation in net income category among its peers.
COMPUGROUP Fundamentals
| Return On Equity | 0.11 | |||
| Return On Asset | 0.031 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.08 % | |||
| Shares Outstanding | 52.23 M | |||
| Price To Earning | 53.50 X | |||
| Revenue | 1.13 B | |||
| Gross Profit | 373.55 M | |||
| EBITDA | 149.63 M | |||
| Net Income | 72.32 M | |||
| Cash And Equivalents | 91.45 M | |||
| Cash Per Share | 1.73 X | |||
| Total Debt | 685.04 M | |||
| Debt To Equity | 1.19 % | |||
| Current Ratio | 0.91 X | |||
| Book Value Per Share | 12.98 X | |||
| Cash Flow From Operations | 165.54 M | |||
| Earnings Per Share | 1.37 X | |||
| Number Of Employees | 8.83 K | |||
| Beta | 1.02 | |||
| Market Capitalization | 2.72 B | |||
| Z Score | 1.8 | |||
| Annual Yield | 0.01 % | |||
| Last Dividend Paid | 0.5 |
About COMPUGROUP MEDSPADR Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze COMPUGROUP MEDSPADR 1's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of COMPUGROUP MEDSPADR using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of COMPUGROUP MEDSPADR 1 based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin | |
| ADA | Cardano | |
| XRP | XRP |
Other Information on Investing in COMPUGROUP Stock
COMPUGROUP MEDSPADR financial ratios help investors to determine whether COMPUGROUP Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in COMPUGROUP with respect to the benefits of owning COMPUGROUP MEDSPADR security.